Search

Author/Creator Im, SA

1. Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial. Issue 12 (December 2019)

Authors:
Park, Yeon Hee; Kim, Tae-Yong; Kim, Gun Min; Kang, Seok Yun; Park, In Hae; Kim, Jee Hyun; Lee, Kyoung Eun; Ahn, Hee Kyung; Lee, Moon Hee; Kim, Hee-Jun; Kim, Han Jo; Lee, Jong In; Koh, Su-Jin; Kim, Ji-Yeon; Lee, Kyung-Hun; Sohn, Joohyuk; Kim, Sung-Bae; Ahn, Jin-Seok; Im, Young-Hyuck; Jung, Kyung Hae
Journal:
Lancet oncology
Issue:
Volume 20:Issue 12(2019)
Page Start:
1750
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search